Wei Li Leong - Chief Financial Officer at BioNexus Gene Lab Corp

Issuer-level insider activity

Role
Chief Financial Officer
Issuer ticker
BGLC on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Wei Li Leong since 13 Aug 2025

Reported holdings for Wei Li Leong in BioNexus Gene Lab Corp

Form 4 holding Chief Financial Officer

BioNexus Gene Lab Corp

Security class
Common Stock, no par value
Shares / value
4,797,709
Estimated value
Report date
19 Jul 2023
Price
Ownership
Direct

Transaction history for Wei Li Leong in BioNexus Gene Lab Corp

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .